CassianRx

Overview

CassianRx is a software-oriented patient engagement and workflow-automation vendor for specialty pharmacy programs. Its public positioning centers on helping patients, providers, pharmacies, and manufacturers coordinate specialty therapy journeys through digital intake, assessments, refill reminders, education, copay workflow support, and program reporting.

For a manufacturer launch team, CassianRx should be evaluated as a digital layer around specialty pharmacy and patient-support workflows, not as a default replacement for a full-service hub, reimbursement casework vendor, or dispensing pharmacy. It is most relevant when the brand wants specialty-pharmacy programs to feel more automated, trackable, and patient-facing while still validating which operational tasks CassianRx owns directly versus what remains with the pharmacy, hub, or manufacturer.

Hub Capability Model

The framework below standardizes how Rx Almanac evaluates hub-services capabilities, so buyers can compare vendors like-for-like while the readout column stays vendor-specific. For this table, CassianRx is evaluated as a software-led patient engagement and specialty-pharmacy workflow layer, not a full-service hub replacement.

Capability	Buyer should compare	CassianRx readout
Therapy initiation and enrollment intake	Digital and human intake, eConsent, missing-information resolution, provider/patient portals, and clean case creation.	Documented software fit. CassianRx can support digital enrollment and intake, but buyers should validate how much human follow-up sits with CassianRx, the specialty pharmacy, or a separate hub.
Benefits verification and coverage triage	Medical/pharmacy benefit verification, eligibility checks, payer-policy lookup, coverage routing, and speed from referral to actionable case.	Not the operating role. CassianRx is not a benefits-verification operator; treat coverage triage as an integration and workflow question with a separate hub or pharmacy partner.
Prior authorization, appeals, and reimbursement casework	PA initiation, payer-specific forms, clinical documentation, appeals, denial management, and field reimbursement handoffs.	Adjacent. CassianRx is an engagement and workflow layer, not a PA / appeals casework vendor — pair with a hub for casework scope.
Affordability, PAP, and copay operations	Copay, free-drug, bridge, foundation, income verification, PAP renewal, and gross-to-net sensitive affordability logic.	Documented adjacency. Copay and manufacturer-program workflow support are relevant, but PAP operations and claims-processing responsibilities should be scoped explicitly.
Patient engagement and adherence operations	Omnichannel reminders, clinical education, nursing or training escalation, persistence outreach, and patient-facing support quality.	Core engagement model. This is the clearest CassianRx fit: digital patient engagement, refill reminders, assessments, education, and adherence-oriented outreach.
Fulfillment, specialty pharmacy, and distribution coordination	Routing to SPs, non-commercial dispensing, DTP shipment, sample/replacement product, 3PL, and cold-chain handoffs.	Partner-dependent. The Lumicera relationship validates specialty-pharmacy workflow relevance, but CassianRx should not be treated as the dispensing or 3PL owner.
Program reporting, integrations, and governance	Manufacturer dashboards, KPI reporting, CRM/EHR/API integrations, SLA governance, and operating visibility across vendors.	Documented but diligence-heavy. Ask for live dashboard examples, data dictionaries, implementation timelines, and integration responsibilities.

Buyer Fit

• When it belongs in the set: Include CassianRx when a specialty brand needs digital patient engagement and workflow automation around an existing specialty-pharmacy or patient-support model.
• Best manufacturer profile: Specialty or biologic products where refill persistence, education, assessment capture, affordability workflow, and patient communication quality matter.
• Where it is less direct: CassianRx is not the first call for outsourced reimbursement casework, stand-alone benefits verification, full PAP administration, dispensing, or distribution.
• Commercial fit: Pricing is Subscription, so scope implementation, integration, service levels, data feeds, and reporting cadence before treating the platform as launch-ready infrastructure.
• Award diligence: Confirm named customer references beyond the Lumicera / Navitus ecosystem, the split of responsibilities with the specialty pharmacy, and which outcomes are independently measured.

Differentiators

• Specialty-pharmacy workflow orientation: CassianRx is built around patient journeys in specialty pharmacy rather than broad consumer engagement.
• ONE Journey platform: ONE Journey gives buyers a named platform to evaluate for intake, assessments, refills, education, copay workflow, and program reporting.
• Lumicera partnership: The Navitus / Lumicera relationship is the most concrete public validation point for how CassianRx can sit inside PBM-adjacent specialty pharmacy operations.
• Omnichannel engagement: Public materials emphasize SMS, email, app, web, and live chat support for patient outreach.
• Compliance posture to diligence: HIPAA audit, FDA 21 CFR Part 11, SOC 2, and ISO 27001-related positioning are relevant for regulated support workflows, but buyers should request current attestations, hosting details, and audit scope.

RFP Questions

• Which patient-support tasks are performed by CassianRx staff, by the specialty pharmacy, by a hub vendor, and by the manufacturer?
• How does the platform support benefits verification, PA, appeals, PAP, or copay claims processing directly, or does it only route and report those workflows?
• What named manufacturer, specialty-pharmacy, or payer references are available beyond the Lumicera / Navitus relationship?
• Which source systems are integrated: pharmacy management systems, CRM, EHR, hub case management, copay platforms, contact center tools, and data warehouses?
• What dashboards, file feeds, data dictionaries, and audit trails are available to manufacturers by brand, patient status, dispense status, and intervention type?
• How are consent, HIPAA, adverse-event routing, product-quality complaints, e-signatures, and 21 CFR Part 11 controls handled?
• Which outcomes are independently measured versus company-reported: engagement, refill persistence, first-fill conversion, abandonment, patient satisfaction, and time-to-therapy?

Recent Activity

• 2021-2022: Lumicera Health Services and CassianRx announced a strategic partnership to support digital patient engagement in specialty pharmacy workflows.
• 2024: CassianRx company materials point to HIPAA audit and FDA 21 CFR Part 11 positioning for regulated digital workflows.
• 2025: Public ecosystem signals include specialty-pharmacy conference presence and continued positioning around automated specialty patient journeys.
• 2026: CassianRx is not a scaled full-service hub or broad named-customer platform; the Lumicera relationship is the primary documented public reference, and buyers should keep reference checks central to diligence beyond it.